Navigation Links
European Multidisciplinary Conference on Thoracic Oncology
Date:3/4/2009

The European Society for Medical Oncology (ESMO), the European Society for Therapeutic Radiology and Oncology (ESTRO), the European Society of Thoracic Surgeons (ESTS) and the European Respiratory Society (ERS) are pleased to announce the first European Multidisciplinary Conference on Thoracic Oncology (EMCTO).

This meeting will provide a comprehensive update and a multidisciplinary perspective of state-of-the-art on the prevention, screening, diagnosis, and treatment of chest tumors, including results of translational research. It will facilitate scientific and clinical exchange, with the aim of promoting an integrated approach to diagnosis, treatment and management of thoracic cancers.

Thoracic cancers are globally recognized as a major cause of mortality. Combating their causes, developing better methods for early detection, advancing research, and improving treatments, require the collaboration of many research and clinical specialties.

Organized in partnership between the European Society for Medical Oncology (ESMO), the European Society for Therapeutic Radiology and Oncology (ESTRO), the European Society of Thoracic Surgeons (ESTS) and the European Respiratory Society (ERS), the conference is designed to provide healthcare professionals with a comprehensive update and a multidisciplinary perspective of state-of-the-art management of patients with thoracic malignancies, including the role of new technologies and the necessary collaboration between various medical specialties.

By bringing together authoritative European partners in thoracic oncology, EMCTO represents an excellent opportunity to promote an integrated approach to diagnosis and treatment of chest tumors and to strengthen European cooperation and scientific exchange .

Meeting highlights:

  • New developments in understanding lung cancer biology
  • Prognostic and predictive factors in non-small-cell lung cancer
  • Critical appraisal of imaging tools in thoracic oncology
  • Individualized staging: practical implications
  • Heterogeneity of locally advanced lung cancer and its implications for treatment
  • Chemoradiotherapy and new developments in radiotherapy
  • Neuroendocrine tumors, mesothelioma and thymoma
  • Individualized therapy based on tumor features
  • Elderly and co-morbid patients
  • Future developments in multidisciplinary treatments

Among the top international experts who have contributed to this multidisciplinary conference: Rolf Stahel, Switzerland; Robert Pirker, Austria; David Gandara, US; Enriqueta Felip, Spain; Giorgio Scagliotti, Italy; Franoise Mornex, France; Paris Kosmidis, Greece; Michael Cullen, UK; Jean-Paul Sculier, Belgium; Cesare Gridelli, Italy; Walter Weder, Switzerland

Meeting venue

The European Multidisciplinary Conference in Thoracic Oncology (EMCTO) will take place at the Palazzo dei Congressi, Lugano.

Services for media representatives

A fully equipped press room will be in operation at the conference with Internet access and telephone lines for registered reporters. You will have access to all the scientific sessions and the possibility to schedule one-on-one interviews with top speakers and presenters of the studies, both in presence and remotely. Please contact the ESMO Communication Dept. at media@esmo.org to already find out about the preliminary timetable or to book a telephone hook up. The conference full program is available at http://www.esmo.org/newsroom/events/

Media registration

To register for the conference as a media representative, please visit http://www.esmo.org/newsroom/events/ and send the Complimentary Media Registration form to the ESMO Communication Department.

Accommodation

For hotel reservation, please visit: http://www.esmo.org/events/lung-2009/book-hotel.html


'/>"/>
Contact: ESMO Press Office
media@esmo.org
41-919-731-907
European Society for Medical Oncology
Source:Eurekalert

Related biology news :

1. Last chance for media to register for ECCO 14 -- the European Cancer Conference
2. 2 French scientists win European award for communication
3. Three-way mating game of North American lizard found in distant European relative
4. European lead in reading past climates from ice cores
5. Hot spots the key to controlling European carp in Australia
6. IdentiPHI Opens Paris Office to Boost European Sales and Support
7. European Union forests expanding, absorbing carbon at surprisingly high rate: study
8. First European Lung Cancer Conference
9. ESFs European ice core project EPICA receives prestigious Descartes Prize
10. European membrane expertise to focus on new treatments for human diseases
11. European light research opens door for optical storage and computing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2016)... , Nov 15, 2016 Research and ... Global Forecast to 2021" report to their offering. ... ... USD 16.18 Billion by 2021 from USD 6.21 Billion in 2016, ... Growth of the bioinformatics market is driven by the ...
(Date:6/22/2016)... 22, 2016  The American College of Medical Genetics and ... Magazine as one of the fastest-growing trade shows during ... the Bellagio in Las Vegas . ... of growth in each of the following categories: net square ... number of attendees. The 2015 ACMG Annual Meeting was ranked ...
(Date:6/20/2016)... June 20, 2016 Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring ... involved, it has secured the final acceptance by ... for Managed Access Systems (MAS) installed. Furthermore, Securus ... to be installed by October, 2016. MAS distinguishes ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  HedgePath Pharmaceuticals, Inc. ... discovers, develops and plans to commercialize innovative therapeutics ... of common stock were approved for trading on ... trading on the OTCQX, effective today, under the ... the OTCQX market, companies must meet high financial ...
(Date:12/8/2016)... , Dec. 8, 2016  Partnering to fuel ... Ben Franklin Technology Partners of Southeastern Pennsylvania ... ("IHG"), the parent company of Independence Blue Cross; and ... announced their intentions for a $6 million funding initiative ... healthcare startups. Responding to a burgeoning economic ...
(Date:12/7/2016)... ... December 07, 2016 , ... A ... “in the setting of previously treated, advanced pancreatic cancer, liquid biopsies are not ... patient population and timing of blood sampling may improve the value of a ...
(Date:12/7/2016)... , Dec. 7, 2016 /PRNewswire/ - OncoQuest ... development and commercialization of immunotherapeutic products for the ... entered into an Antibody Manufacturing Development Program with ... , USA) for its oregovomab antibody product. Supported ... Phase IIb clinical study in ovarian cancer patients, ...
Breaking Biology Technology: